ArticleOncology letters2026

PD-1 inhibitors combined with tyrosine kinase inhibitor-associated hypothyroidism is a predictive factor for antitumor effectiveness in male patients with hepatocellular carcinoma.

Bailu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.